Genetic and Metabolic Markers for Cognition: The Interplay of Hyperhomocysteinemia and ApoE Genotype

Abstract Background The presence of ApoE4 allele is known to be the most important genetic risk factor for Late Onset Alzheimer's Disease (LOAD). Hyperhomocysteinemia (HHcy), a cardiovascular risk factor, is also being extensively studied for its role in increasing the risk of cognitive decline in the elderly. The current study aims to explore if any interaction exists between HHcy and ApoE4 allele with respect to their association with cognition. Method The study recruited 750 participants from the Tata Longitudinal Study of Ageing (TLSA), an ongoing cohort study of individuals aged ≥ 45 years. The Computerised Assessment of Adult Information Processing (COGNITO) neuropsychological battery was used to assess cognitive performance. Homocysteine levels were quantified using chemiluminescence immunoassays. ApoE genotype was determined using Polymerase Chain Reaction (PCR) amplification followed by Sanger sequencing. Generalised Linear Model (GLM) was used to study the interaction between HHcy and ApoE4 allele on cognition. Result The GLM identified that the HHcy/ApoE4 non‐carriers had impaired performance in reading and sentence comprehension (B=‐0.190; p = 0.047) and form matching (B=‐0.335; p = 0.029) tasks. Such impairment was not observed in the HHcy/ApoE4 carriers group. In the name‐face association task, only the HHcy/ApoE E4 carriers group (B=‐0.672; p = 0.037) had lower scores when compared to the reference group. In episodic memory immediate recall task, both HHcy/ApoE E4 non‐carriers (B=‐0.323; p = 0.015) and HHcy/ApoE E4 carriers (B=‐0.423; p = 0.040) groups had lower scores. Conclusion The results suggest that the association of HHcy with impairment in memory‐related tasks was seen irrespective of ApoE4 carrier status, but is exaggerated in ApoE4 carriers. In tasks related to language and visuo‐spatial abilities, the ApoE4 carriers had no association with the scores even if they had HHcy. Thus, the study results imply that HHcy affects cognitive functioning, but ApoE4 allele modulates the relationship only in non‐memory domains.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70856_106720
Primary Topic
Folate and B Vitamins Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetic and Metabolic Markers for Cognition: The Interplay of Hyperhomocysteinemia and ApoE Genotype

Monisha S, Thomas Gregor Issac, Sandhya Gandhi Natarajan
Alzheimer s & Dementia
Folate and B Vitamins Research
article

Genetic and Metabolic Markers for Cognition: The Interplay of Hyperhomocysteinemia and ApoE Genotype

Monisha S, Thomas Gregor Issac, Sandhya Gandhi Natarajan
article en

Abstract

Abstract Background The presence of ApoE4 allele is known to be the most important genetic risk factor for Late Onset Alzheimer's Disease (LOAD). Hyperhomocysteinemia (HHcy), a cardiovascular risk factor, is also being extensively studied for its role in increasing the risk of cognitive decline in the elderly. The current study aims to explore if any interaction exists between HHcy and ApoE4 allele with respect to their association with cognition. Method The study recruited 750 participants from the Tata Longitudinal Study of Ageing (TLSA), an ongoing cohort study of individuals aged ≥ 45 years. The Computerised Assessment of Adult Information Processing (COGNITO) neuropsychological battery was used to assess cognitive performance. Homocysteine levels were quantified using chemiluminescence immunoassays. ApoE genotype was determined using Polymerase Chain Reaction (PCR) amplification followed by Sanger sequencing. Generalised Linear Model (GLM) was used to study the interaction between HHcy and ApoE4 allele on cognition. Result The GLM identified that the HHcy/ApoE4 non‐carriers had impaired performance in reading and sentence comprehension (B=‐0.190; p = 0.047) and form matching (B=‐0.335; p = 0.029) tasks. Such impairment was not observed in the HHcy/ApoE4 carriers group. In the name‐face association task, only the HHcy/ApoE E4 carriers group (B=‐0.672; p = 0.037) had lower scores when compared to the reference group. In episodic memory immediate recall task, both HHcy/ApoE E4 non‐carriers (B=‐0.323; p = 0.015) and HHcy/ApoE E4 carriers (B=‐0.423; p = 0.040) groups had lower scores. Conclusion The results suggest that the association of HHcy with impairment in memory‐related tasks was seen irrespective of ApoE4 carrier status, but is exaggerated in ApoE4 carriers. In tasks related to language and visuo‐spatial abilities, the ApoE4 carriers had no association with the scores even if they had HHcy. Thus, the study results imply that HHcy affects cognitive functioning, but ApoE4 allele modulates the relationship only in non‐memory domains.

Alzheimer s & DementiaVol. 21(S2)
Bangalore Diabetes Centre (IN), Indian Institute of Science Bangalore (IN)
Quality Education
Openalex Percentile: Top 25%
Folate and B Vitamins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.